Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMissing a few weeks of Wegovy does not automatically mean starting from scratch. Most people can resume at their previous dose if the gap is four weeks or less; beyond that, restarting at a lower dose is usually the safer clinical choice to avoid unpleasant side effects. Whether your break was planned or forced, the right re-entry point depends on how long you were off treatment, which dose you were on, and how your body responded the first time round. These medicines are prescription-only, so any decision about restarting should be made with your prescriber, not based on a rule of thumb from a forum.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common worry people bring to this question is all-or-nothing thinking: that any time off Wegovy wipes the slate clean and forces a slow, frustrating climb back through every dose. That is not how it works. The Wegovy dose schedule (0.25mg, 0.5mg, 1.0mg, 1.7mg and 2.4mg, titrated roughly every four weeks by your prescriber) exists primarily to let your digestive system adapt, not because each step delivers a fundamentally different medicine.
If your gap was short, your tolerance is likely still in place. The NHS patient guidance on semaglutide is consistent with clinical practice here: a missed dose of up to four weeks does not require restarting the titration. You take your next dose as scheduled. Miss by more than four weeks and stepping back is the standard approach, because the gastrointestinal side effects (nausea, reflux, loose stools) can return at full force if you go straight back to a high dose after a longer absence.
That said, four weeks is a guideline, not a guarantee. Someone who struggled badly with nausea at 1.7mg the first time round may need more caution than someone who tolerated 2.4mg without issue. Your prescriber is the right person to make that call, drawing on your full history rather than just the calendar.
This is the part many people find disheartening. Wegovy works partly by slowing gastric emptying and reducing appetite signals; when you stop, those effects fade quickly. Appetite often returns to pre-treatment levels within days to a couple of weeks, and some people find it rebounds sharply. The STEP 1 trial, published in the New England Journal of Medicine, followed participants after treatment ended and found that a significant proportion of lost weight was regained within a year of stopping, underlining that these medicines work while you take them, not permanently in the background.
Understanding this matters for restarting decisions. If you've had a long gap and regained weight, your prescriber may want a fresh picture of your current BMI, blood pressure and any changes to your health before recommending a re-entry dose. That's not bureaucracy — it's the kind of oversight that makes the difference between a smooth restart and a miserable few weeks of side effects on too high a dose too soon. If you're also wondering how long after starting Wegovy you will lose weight, that's a useful question to have answered before you begin again, so you go in with realistic expectations for the restart phase.
A note on timing: if you're planning to restart and want same-day clinical review, ordering before 12pm on a weekday makes a practical difference to when your prescription reaches a prescriber's desk that day.
There are situations where going back to the bottom of the dose ladder is not just cautious but necessary. Gaps longer than two to three months are an obvious example. So are changes in your circumstances (a new diagnosis, a new medicine that might interact, pregnancy status, or a recent surgery) any of which could mean the dose that suited you before no longer suits you now. If your break was involuntary, perhaps because of a supply shortage, it is worth reading about what to do when Wegovy stops producing the results you expected, since the restart experience can feel similar.
People who stopped because side effects became unmanageable should be especially careful. Going straight back to the dose that caused the problem is unlikely to go better the second time; a more cautious retitration, with slower steps, is often the approach a prescriber will recommend. The broader NHS England guidance on weight-management injections emphasises that clinical supervision throughout treatment, including during any breaks and restarts, is part of what makes these medicines safe to use long term.
For context on treatment costs if you are restarting privately, the Wegovy pricing page sets out what a private prescription typically covers. And if you want a broader view of all licensed weight-loss treatment options currently available in the UK, our treatment overview is a good starting point.
Before you pick up where you left off, it's worth running through a short mental list. How long was the gap, exactly? Have your weight or health circumstances changed materially? Did you experience significant side effects before stopping? Are you on any new medicines, including oral contraceptives, given that tirzepatide and some GLP-1 treatments can affect pill absorption, though the relevant advice for semaglutide is somewhat different? These are the questions a prescriber will ask, and thinking them through first makes the consultation faster and more useful.
If you stopped Wegovy and are now wondering whether a different treatment might suit you better, our guide to what to expect when starting Wegovy can help you compare the restart experience with what beginning felt like the first time. And if you are curious how the early weeks of treatment tend to unfold in terms of weight changes, this page on the typical timeline before weight loss begins gives an honest picture. Speak to our prescribers if you would like a personalised review before restarting, a free consultation is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.